Delivered-To: josh@josh.is
Received: by 2002:a59:be92:0:b0:234:5aa1:1208 with SMTP id bl18csp4369521vqb;
        Tue, 28 Sep 2021 02:30:57 -0700 (PDT)
X-Received: by 2002:ad4:54b2:: with SMTP id r18mr4355056qvy.6.1632821457661;
        Tue, 28 Sep 2021 02:30:57 -0700 (PDT)
ARC-Seal: i=1; a=rsa-sha256; t=1632821457; cv=none;
        d=google.com; s=arc-20160816;
        b=w5WqkJaxwb0+9M8TljYnPhku96vOWtmtGWwLrAzW+A8uWikAdZTAagMaAYDYpqJ82n
         5MgyYrDZbGkOi/C2SUlRz/ghbsJuGq9RVgYgOeT8iRDs8Lb7xap5hzgbDpb4PCz+w6BB
         Lb2kED6ph2fZ/sa/Q0lZvb1wEMPyr9VZsZOOcw6lK3oMhnDaLtaufHCXd0JDxP/4ehfV
         v81E6rBp7E5uwslxEnEIHq3e8lc3k/tXnlwkaj9DDrOa9FVmEu0XxokWCaE7wmTMIlyd
         9qbG/QcdLeOw4TJ/cjLP0ntH24vQJak/HWBrae8VK6JFK5gOfqfBlenR86aQPQEgafMD
         oE2g==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=to:subject:message-id:date:from:in-reply-to:references:mime-version
         :dkim-signature;
        bh=6EwKykStCO6MoWyvWW9UyrSGApqGi3H6qfI1oQBSMaY=;
        b=j6LrwjSGibI/oJbOLt0K8APuCUZANkgWWqYDOdJAtYn/M8pix6kqYjN/t+pn/iW9VW
         LL+k9olhsD6CWrG3ejfzJU0fMtmict0qQx/I3+HgHBnIW8Ny2EyjBIjSbrI7H+sfqpo9
         NY6MOlMikZhE51A0LaKj7rm8bXHoVMzzbG666an+c1ugnat00fzQCJ9IkSyd0FUF7+yN
         qqXTU+lYeTm+djWDOZcVuRCVeNMDTBK59PlJQxTxHnk/SGPUAEBmY90G8yBXwNoCq5lc
         vAYwsj698Ck9VTFXixHe2J3lbLxa4/DhwDORSThPQWkPyvea9u0CR2HlRnpxBul+a8QY
         YC9Q==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@startupiceland-com.20210112.gappssmtp.com header.s=20210112 header.b=UiLsCbRE;
       spf=neutral (google.com: 209.85.220.41 is neither permitted nor denied by best guess record for domain of bala@startupiceland.com) smtp.mailfrom=bala@startupiceland.com
Return-Path: <bala@startupiceland.com>
Received: from mail-sor-f41.google.com (mail-sor-f41.google.com. [209.85.220.41])
        by mx.google.com with SMTPS id h15sor18316039qtx.16.2021.09.28.02.30.57
        for <josh@josh.is>
        (Google Transport Security);
        Tue, 28 Sep 2021 02:30:57 -0700 (PDT)
Received-SPF: neutral (google.com: 209.85.220.41 is neither permitted nor denied by best guess record for domain of bala@startupiceland.com) client-ip=209.85.220.41;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@startupiceland-com.20210112.gappssmtp.com header.s=20210112 header.b=UiLsCbRE;
       spf=neutral (google.com: 209.85.220.41 is neither permitted nor denied by best guess record for domain of bala@startupiceland.com) smtp.mailfrom=bala@startupiceland.com
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=startupiceland-com.20210112.gappssmtp.com; s=20210112;
        h=mime-version:references:in-reply-to:from:date:message-id:subject:to;
        bh=6EwKykStCO6MoWyvWW9UyrSGApqGi3H6qfI1oQBSMaY=;
        b=UiLsCbREkqRPukLwsFFdZV0U9aQOQDpS4AX+G2hUckXQ7DEQOt4OU6+9SJeIZqs8AH
         2w/+OeWqIFRiC174at01/17hlSuq1IWsiLRcYydMpTGWPcdSeDHemVfTVWZAjKu7S0U8
         s2oNbCV5PMNvvlovoKfk8xxHNQkKUOeK6VHvDeaZvCpkB0aRDCJHlHpuVzizcQV7w3K9
         8Jr+0icvUMjcS2Rl8ip6D51vToXH8A0JvsJC93tqNgblwQbRKNX8npMbaezwix3u/ebv
         IqMiyubRjKDBDLF4H9vrBXUnKaiXZCWk9Um7DC9GbGaTk3bgkhcZm1FSxorjFZu3C0kQ
         Wwsg==
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=1e100.net; s=20210112;
        h=x-gm-message-state:mime-version:references:in-reply-to:from:date
         :message-id:subject:to;
        bh=6EwKykStCO6MoWyvWW9UyrSGApqGi3H6qfI1oQBSMaY=;
        b=rEj00gE7u8fMCWwttHMfyq9A7D/XJZyqQFcBYxRpbcVFIENl7EqFNYY4b7NVaBNVli
         PUcjx36dyXq6S+mzpdFM+VTop/JRUdZDizzAkxz+zs7KvF1rc3izJzxR0KXQ212jjj3N
         gk7ndKxTxZweMPqzSKWXnbqdAblvh/PhxHyCTtDFFZJ2ODZi0YxKyFfwxhJq4zvNfyEN
         /3SEomUeoFerz2NwE7Ww7kPTZEj8r19Bt9gChZ2MiKsIcz0pYvG3UGfB3u+VG8lUeY7R
         djQci157b6cWUi1VkZ8A+HIFEJOGt8iTGvcCUFOry8lK8MlaaKrq9v4xnG7GA+L9n0Ff
         RxUA==
X-Gm-Message-State: AOAM533Lbh/G3Vlb3CgM6+XQwWcr4vOUwE5lUKHnz36ME8SoJ4rd7Vq8
	enbzwQ8EolClmYIZb/Xn3rHyqjcH2UttsJqvu0dZjlInrMY=
X-Google-Smtp-Source: ABdhPJzDPbbvGsD95HcRdT57j5jfOHVkqboZB5YkLBO1NGy6CLc+qif8PU4BJgWRrSQR0FfX5HEdyYc9MF0KeZ2MvTw=
X-Received: by 2002:ac8:7681:: with SMTP id g1mr4350525qtr.225.1632821456898;
 Tue, 28 Sep 2021 02:30:56 -0700 (PDT)
MIME-Version: 1.0
References: <CACNgykOiH7sZDdjqw5HX5rHpHfQDJPpc=LJxswbv0wi92MDFBg@mail.gmail.com>
 <CAJNeY2x50KLZtcbxYyu0CVEBPmsUjB+KKnZdFhw_tAuqWeOQVg@mail.gmail.com>
 <CACNgykN+GEB0ZAeDMnOkFv9=Gwc5qvVAvN8x9fDYaOKQU-HUTA@mail.gmail.com>
 <CAJNeY2xsaZAW0Rfyc3QfyvUTGCmopop_te+yot93SiiaujVgWQ@mail.gmail.com> <CACNgykMJd9czMz6Y6yVji4NbdGx4cVnbbwFPWS0TcWZv3tnWzw@mail.gmail.com>
In-Reply-To: <CACNgykMJd9czMz6Y6yVji4NbdGx4cVnbbwFPWS0TcWZv3tnWzw@mail.gmail.com>
From: Bala Kamallakharan <bala@startupiceland.com>
Date: Tue, 28 Sep 2021 09:30:45 +0000
Message-ID: <CAJNeY2x5Gk6eYs2N0mKoqdfLTBbCQhsdP8+v6752Wd9rFRFOZw@mail.gmail.com>
Subject: Re: Decode
To: Josh Klein <josh@josh.is>
Content-Type: multipart/alternative; boundary="000000000000eb9e1c05cd0ade0e"

--000000000000eb9e1c05cd0ade0e
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Retina Risk has over +1million data points of Biomarker data and it is not
just an App, we have an API business and Web 3 web portal business that
allows anyone with a website to use the Algorithm to serve diabetic
patients.

On Tue, Sep 28, 2021 at 9:24 AM Josh Klein <josh@josh.is> wrote:

> Sounds interesting, but isn't this proposal orthogonal to their app-based
> approach? My impression was that DeCode's genetic database and larger siz=
e
> would make an easier pitch to J&J. I'll reach out to Silla to reconnect
> regardless (especially if they're looking at other risk vectors now) but
> would be curious if you think it's also worth connecting with DeCode.
>
>
> =E1=90=A7
>
> On Mon, Sep 27, 2021 at 3:00 PM Bala Kamallakharan <
> bala@startupiceland.com> wrote:
>
>> Not sure if Decode will engage, have you tried contacting Silla with
>> Retina Risk? They have data and are doing more Risk Algorithms for a num=
ber
>> of other risks like Heart Disease, Kidney disease etc
>>
>> On Mon, Sep 27, 2021 at 2:49 PM Josh Klein <josh@josh.is> wrote:
>>
>>> Fantastic news about Fund II; really interested to hear your posits on
>>> that particular market!!
>>>
>>> Reg. the CGM project, I've attached the overview deck. The interest in
>>> Iceland is given it's meteoric rise in diabetes, fast-follower culture,
>>> high medical adherence, and strong genetic data store.
>>>
>>> TL;DR: A scaled Bayesian filtering process* can isolate the most
>>> effective UX for behavior change... rather than starting with the data =
and
>>> trying to convince the consumer to care about it directly. Success woul=
d
>>> mean an instant new market for an existing product to improve health
>>> outcomes for heart disease, obesity, and diabetes, as well as a new
>>> methodology for quickly isolating effective new product designs pre-mar=
ket.
>>>
>>> Let me know if that makes any sense!
>>>
>>> All best,
>>> Josh
>>>
>>> * Using the different data types presented through different interface
>>> designs in different timescales in different orders.
>>> =E1=90=A7
>>>
>>> On Mon, Sep 27, 2021 at 11:40 AM Bala Kamallakharan <
>>> bala@startupiceland.com> wrote:
>>>
>>>> Hi Josh,
>>>>
>>>> Nice to hear from you. Yes, I know some people but who is the right on=
e
>>>> to talk to about this? If you give me some specifics then it is easier=
 to
>>>> navigate.
>>>>
>>>> All good with Iceland Venture Studio and I am done with Fund I and now
>>>> starting Fund II focused on India with the same investment thesis.
>>>>
>>>> Regards
>>>> Bala
>>>>
>>>> On Mon, Sep 27, 2021 at 11:22 AM Josh Klein <josh@josh.is> wrote:
>>>>
>>>>> Bala,
>>>>>
>>>>> I've been working on a CGM test protocol proposal and am speaking to
>>>>> some senior executives at Novo Nordisk and J&J. I'd like to propose I=
celand
>>>>> as a potential test case and potentially partner with DeCode to run t=
he
>>>>> logistics. Do you have any contacts there?
>>>>>
>>>>> Otherwise how are you? It's an interesting time in the investment
>>>>> community! Let me know if I can be of any help.
>>>>>
>>>>> All best,
>>>>> Josh
>>>>> =E1=90=A7
>>>>>
>>>>
>>>>
>>>> --
>>>> Bala Kamallakharan
>>>> Founder
>>>> Startup Iceland
>>>> Twitter: @BalaInIceland @startupiceland
>>>> <https://twitter.com/#!/startupiceland>
>>>> Facebook: http://facebook.com/startupiceland
>>>> Blog: http://startupiceland.com/blog
>>>> Conference: http://startupiceland.com
>>>>
>>>
>>
>> --
>> Bala Kamallakharan
>> Founder
>> Startup Iceland
>> Twitter: @BalaInIceland @startupiceland
>> <https://twitter.com/#!/startupiceland>
>> Facebook: http://facebook.com/startupiceland
>> Blog: http://startupiceland.com/blog
>> Conference: http://startupiceland.com
>>
>

--=20
Bala Kamallakharan
Founder
Startup Iceland
Twitter: @BalaInIceland @startupiceland
<https://twitter.com/#!/startupiceland>
Facebook: http://facebook.com/startupiceland
Blog: http://startupiceland.com/blog
Conference: http://startupiceland.com

--000000000000eb9e1c05cd0ade0e
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Retina Risk has over +1million data points of Biomarker da=
ta and it is not just an App, we have an API business and Web 3 web portal =
business that allows anyone with a website to use the Algorithm to serve di=
abetic patients. <br></div><br><div class=3D"gmail_quote"><div dir=3D"ltr" =
class=3D"gmail_attr">On Tue, Sep 28, 2021 at 9:24 AM Josh Klein &lt;<a href=
=3D"mailto:josh@josh.is">josh@josh.is</a>&gt; wrote:<br></div><blockquote c=
lass=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8ex;border-left:1px soli=
d rgb(204,204,204);padding-left:1ex"><div dir=3D"ltr">Sounds interesting, b=
ut isn&#39;t this proposal orthogonal=C2=A0to their app-based approach? My =
impression was that DeCode&#39;s=C2=A0genetic database and larger size woul=
d make an easier pitch to J&amp;J. I&#39;ll reach out to Silla to reconnect=
 regardless (especially if they&#39;re looking at other risk vectors now) b=
ut would be curious if you think it&#39;s also worth connecting with DeCode=
.<div><br></div><div><br></div></div><div hspace=3D"streak-pt-mark" style=
=3D"max-height:1px"><img alt=3D"" style=3D"width: 0px; max-height: 0px; ove=
rflow: hidden;" src=3D"https://mailfoogae.appspot.com/t?sender=3Daam9zaEBqb=
3NoLmlz&amp;type=3Dzerocontent&amp;guid=3D7fddc322-457b-4919-8a44-bef2329c1=
98d"><font size=3D"1" color=3D"#ffffff">=E1=90=A7</font></div><br><div clas=
s=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">On Mon, Sep 27, 202=
1 at 3:00 PM Bala Kamallakharan &lt;<a href=3D"mailto:bala@startupiceland.c=
om" target=3D"_blank">bala@startupiceland.com</a>&gt; wrote:<br></div><bloc=
kquote class=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8ex;border-left:=
1px solid rgb(204,204,204);padding-left:1ex"><div dir=3D"ltr">Not sure if D=
ecode will engage, have you tried contacting Silla with Retina Risk? They h=
ave data and are doing more Risk Algorithms for a number of other risks lik=
e Heart Disease, Kidney disease etc<br></div><br><div class=3D"gmail_quote"=
><div dir=3D"ltr" class=3D"gmail_attr">On Mon, Sep 27, 2021 at 2:49 PM Josh=
 Klein &lt;<a href=3D"mailto:josh@josh.is" target=3D"_blank">josh@josh.is</=
a>&gt; wrote:<br></div><blockquote class=3D"gmail_quote" style=3D"margin:0p=
x 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><d=
iv dir=3D"ltr">Fantastic news about Fund II; really interested to hear your=
 posits on that particular market!!<div><br></div><div>Reg. the CGM project=
, I&#39;ve attached the overview deck. The interest in Iceland is given it&=
#39;s meteoric rise in diabetes, fast-follower culture, high medical adhere=
nce, and strong genetic data store.=C2=A0</div><div><br></div><div>TL;DR: A=
 scaled Bayesian=C2=A0filtering process* can isolate the most effective UX =
for behavior change... rather=C2=A0than starting with the data and trying t=
o convince the consumer to care about it directly. Success would mean an in=
stant new market for an existing product to improve health outcomes for hea=
rt disease, obesity, and diabetes, as well as a new methodology for quickly=
 isolating effective new product designs pre-market.=C2=A0</div><div><br></=
div><div>Let me know if that makes any sense!</div><div><br></div><div>All =
best,</div><div>Josh</div><div><br></div><div>*=C2=A0Using the different da=
ta types presented through different interface designs in different timesca=
les in different orders.</div></div><div hspace=3D"streak-pt-mark" style=3D=
"max-height:1px"><img alt=3D"" style=3D"width: 0px; max-height: 0px; overfl=
ow: hidden;" src=3D"https://mailfoogae.appspot.com/t?sender=3Daam9zaEBqb3No=
Lmlz&amp;type=3Dzerocontent&amp;guid=3D179d8def-b79a-405b-af35-c0dd385bd7c7=
"><font size=3D"1" color=3D"#ffffff">=E1=90=A7</font></div><br><div class=
=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">On Mon, Sep 27, 2021=
 at 11:40 AM Bala Kamallakharan &lt;<a href=3D"mailto:bala@startupiceland.c=
om" target=3D"_blank">bala@startupiceland.com</a>&gt; wrote:<br></div><bloc=
kquote class=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8ex;border-left:=
1px solid rgb(204,204,204);padding-left:1ex"><div dir=3D"ltr"><div>Hi Josh,=
</div><div><br></div><div>Nice to hear from you. Yes, I know some people bu=
t who is the right one to talk to about this? If you give me some specifics=
 then it is easier to navigate. <br></div><div><br></div><div>All good with=
 Iceland Venture Studio and I am done with Fund I and now starting Fund II =
focused on India with the same investment thesis. <br></div><div><br></div>=
<div>Regards</div><div>Bala<br></div></div><br><div class=3D"gmail_quote"><=
div dir=3D"ltr" class=3D"gmail_attr">On Mon, Sep 27, 2021 at 11:22 AM Josh =
Klein &lt;<a href=3D"mailto:josh@josh.is" target=3D"_blank">josh@josh.is</a=
>&gt; wrote:<br></div><blockquote class=3D"gmail_quote" style=3D"margin:0px=
 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><di=
v dir=3D"ltr">Bala,<div><br></div><div>I&#39;ve been working on a CGM test =
protocol proposal and am speaking to some senior executives at Novo Nordisk=
 and J&amp;J. I&#39;d like to propose Iceland as a potential test case and =
potentially partner with DeCode to run the logistics. Do you have any conta=
cts there?</div><div><br></div><div>Otherwise how are you? It&#39;s an inte=
resting time=C2=A0in the investment community! Let me know if I can be of a=
ny help.</div><div><br></div><div>All best,</div><div>Josh</div></div><div =
hspace=3D"streak-pt-mark" style=3D"max-height:1px"><img alt=3D"" style=3D"w=
idth: 0px; max-height: 0px; overflow: hidden;" src=3D"https://mailfoogae.ap=
pspot.com/t?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocontent&amp;guid=3Dc9=
6325f2-19c4-4032-a9aa-980b58640684"><font size=3D"1" color=3D"#ffffff">=E1=
=90=A7</font></div>
</blockquote></div><br clear=3D"all"><br>-- <br><div dir=3D"ltr"><div dir=
=3D"ltr"><div><div></div><div><font face=3D"&#39;arial narrow&#39;, sans-se=
rif" color=3D"#333333">Bala Kamallakharan</font></div><div><div><font face=
=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">Founder</font></d=
iv><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333"=
>Startup Iceland</font></div><div><font face=3D"&#39;arial narrow&#39;, san=
s-serif" color=3D"#333333">Twitter: @BalaInIceland @<a href=3D"https://twit=
ter.com/#!/startupiceland" target=3D"_blank">startupiceland</a></font></div=
><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">F=
acebook: <a href=3D"http://facebook.com/startupiceland" target=3D"_blank">h=
ttp://facebook.com/startupiceland</a></font></div><div><font face=3D"&#39;a=
rial narrow&#39;, sans-serif" color=3D"#333333">Blog: <a href=3D"http://sta=
rtupiceland.com/blog" target=3D"_blank">http://startupiceland.com/blog</a><=
/font></div><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D=
"#333333">Conference: <a href=3D"http://startupiceland.com" target=3D"_blan=
k">http://startupiceland.com</a></font></div></div></div></div></div>
</blockquote></div>
</blockquote></div><br clear=3D"all"><br>-- <br><div dir=3D"ltr"><div dir=
=3D"ltr"><div><div></div><div><font face=3D"&#39;arial narrow&#39;, sans-se=
rif" color=3D"#333333">Bala Kamallakharan</font></div><div><div><font face=
=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">Founder</font></d=
iv><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333"=
>Startup Iceland</font></div><div><font face=3D"&#39;arial narrow&#39;, san=
s-serif" color=3D"#333333">Twitter: @BalaInIceland @<a href=3D"https://twit=
ter.com/#!/startupiceland" target=3D"_blank">startupiceland</a></font></div=
><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">F=
acebook: <a href=3D"http://facebook.com/startupiceland" target=3D"_blank">h=
ttp://facebook.com/startupiceland</a></font></div><div><font face=3D"&#39;a=
rial narrow&#39;, sans-serif" color=3D"#333333">Blog: <a href=3D"http://sta=
rtupiceland.com/blog" target=3D"_blank">http://startupiceland.com/blog</a><=
/font></div><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D=
"#333333">Conference: <a href=3D"http://startupiceland.com" target=3D"_blan=
k">http://startupiceland.com</a></font></div></div></div></div></div>
</blockquote></div>
</blockquote></div><br clear=3D"all"><br>-- <br><div dir=3D"ltr" class=3D"g=
mail_signature"><div dir=3D"ltr"><div><div></div><div><font face=3D"&#39;ar=
ial narrow&#39;, sans-serif" color=3D"#333333">Bala Kamallakharan</font></d=
iv><div><div><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#33=
3333">Founder</font></div><div><font face=3D"&#39;arial narrow&#39;, sans-s=
erif" color=3D"#333333">Startup Iceland</font></div><div><font face=3D"&#39=
;arial narrow&#39;, sans-serif" color=3D"#333333">Twitter: @BalaInIceland @=
<a href=3D"https://twitter.com/#!/startupiceland" target=3D"_blank">startup=
iceland</a></font></div><div><font face=3D"&#39;arial narrow&#39;, sans-ser=
if" color=3D"#333333">Facebook: <a href=3D"http://facebook.com/startupicela=
nd" target=3D"_blank">http://facebook.com/startupiceland</a></font></div><d=
iv><font face=3D"&#39;arial narrow&#39;, sans-serif" color=3D"#333333">Blog=
: <a href=3D"http://startupiceland.com/blog" target=3D"_blank">http://start=
upiceland.com/blog</a></font></div><div><font face=3D"&#39;arial narrow&#39=
;, sans-serif" color=3D"#333333">Conference: <a href=3D"http://startupicela=
nd.com" target=3D"_blank">http://startupiceland.com</a></font></div></div><=
/div></div></div>

--000000000000eb9e1c05cd0ade0e--
